SLC5A2 and thyroid gland carcinoma: Meanwhile, the SGLT2 levels were a potential biomarker for patients with thyroid cancer in TCGA dataset, with an AUC of 0.879 (95% confidence interval: 0.849‐0.905), a sensitivity value of 81.91% and a specificity value of 87.93% (Fig. 6B).